Atlas Trials

A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

Clinical trial NCT06769919 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06769919
Sponsor
Xijing Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-12-31
Primary completion
2026-12-31
Enrollment
340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.